Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Industry News

STENTYS: Journal of the American College of Cardiology Publication Shows Malapposition Influences Death from Early Stent Thrombosis

May 07, 2014

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium

October 31, 2013

News Industry News

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

October 28, 2013

News Industry News

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

October 22, 2013

News Industry News

OrbusNeich Launches World’s First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents

May 27, 2013

News Industry News

Arterial Remodeling Technologies (ART) reports first human use of its next-generation bioresorbable stent

July 16, 2012

News Industry News

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

July 03, 2012

News Industry News

ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent

May 15, 2012

News Industry News

Virmani's crystal ball: Transcatheter valves

November 06, 2011

News Industry News

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

July 11, 2011

News Industry News

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

May 12, 2011

Advertisement

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

STENTYS: Journal of the American College of Cardiology Publication Shows Malapposition Influences Death from Early Stent Thrombosis

OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

OrbusNeich Launches World’s First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents

Arterial Remodeling Technologies (ART) reports first human use of its next-generation bioresorbable stent

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent

Virmani's crystal ball: Transcatheter valves

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content